Foundation Medicine Highlights Actionable Data from First Patient Samples Analyzed on NGS Cancer Dx
January 25, 2012
Foundation Medicine Highlights Actionable Data from First Patient Samples Analyzed on NGS Cancer Dx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Foundation Medicine, MSKCC to Develop Sequencing-based Blood Cancer Test from DNA, RNA
May 8, 2013 / Clinical Sequencing News - Genomic Health to Launch NGS-based Somatic Cancer Mutation Detection Platform for Pharma Research
January 25, 2012 / Pharmacogenomics Reporter - Foundation Medicine Raises $33.5M to Support Commercialization of Cancer Dx Panel
October 19, 2011 / Clinical Sequencing News - Foundation Medicine Shows Sequencing-based Cancer Test Can ID Clinically Actionable Mutations
June 8, 2011 / Clinical Sequencing News - People in the News
May 17, 2011 / Clinical Sequencing News